CIT joins ScreenTox toxicology project

Published: 13-Jan-2011

Colipa co-funded project aims to find toxicology testing alternatives


Contract research organisation CIT is to join a five year €50m joint research and development project funded by Colipa and the Health Programme of the European Commission which aims to address the as yet unmet need for test methods to predict toxicology of drugs, chemicals and cosmetic ingredients.

The ScreenTox (Stem Cells for Relevant, Efficient, Extended & Normalised Toxicology) project will involve 14 industrial and academic partners and will be co-ordinated by Inserm, the French National Institute for Health and Medical Research.

“ScreenTox has the potential to generate a huge leap forward in toxicology testing as it combines three key factors: a wide range of international expertise and industry know-how as well as substantial financial investment,” commented Ray Forster, scientific director, CIT. “We believe that ScreenTox will demonstrate advantages in using stem cells to assess how safe new products will be for use on humans and in refining, reducing or even replacing the use of animals for testing.”

You may also like